510(k) · Cleared
ClearedSeare Biomedical Silicone Sheeting
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Seare Biomedical Corp. · MIB Elastomer, Silicone Block
Cleared on Sep 30, 1998 after a 30-day review. The FDA summary names its predicate without a number. 1 later device descends from it.
- Decided
- Sep 30, 1998
- Review
- 30 days
- Class
- Class II
- Product code
- MIB
- Recalls
- None
- Predicates
- 0
1 later device descends from it, 1 citing it directly.
- This deviceK983041 Seare Biomedical Silicone SheetingSeare Biomedical Corp. · 1998
- Descendant · cites it directly · 0 of its ownK071823 Perma Facial ImplantsSurgisil · 2007
Most influential descendants
Showing 1 of 1 · See all- K071823Perma Facial ImplantsSurgisil · 2007 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| 0 (this device) | K983041 | Seare Biomedical Silicone Sheeting | Seare Biomedical Corp. | 1998 | — |
| +1 | K071823 | Perma Facial Implants | Surgisil | 2007 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2007 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in MIB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new MIB device
- #1 K241150 MISTI Silicone Implantscore 8.0 · 2 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | — | Silicone Elastomer Sheeting manufactured and marketed by Dow Corning Named without a submission number | |
| * | — | Silicone Elastomer Sheeting manufactured and marketed by Bentec Medical Named without a submission number |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K071823 | Perma Facial Implants | 2007 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- Of its descendants, K071823 (Surgisil, 2007) has gone furthest, with 0 descendants of its own.
How does its category compare?
All MIB devicesMIB Elastomer, Silicone Block: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · MIB
1in 2024
2026 to Oct 25, outlined.
Median 510(k) review, days · MIB
102in 2022
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · MIB
3in 2025
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · MIB
18in 2025
MAUDE reports naming product code MIB, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 2 |
| 2011 | 0 | — | 0 | 1 |
| 2012 | 0 | — | 0 | 2 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 1 |
| 2015 | 0 | — | 0 | 2 |
| 2016 | 0 | — | 0 | 1 |
| 2017 | 1 | — | 0 | 1 |
| 2018 | 1 | — | 0 | 10 |
| 2019 | 1 | — | 0 | 3 |
| 2020 | 1 | — | 0 | 1 |
| 2021 | 0 | — | 0 | 5 |
| 2022 | 3 | 102 | 0 | 19 |
| 2023 | 1 | — | 0 | 74 |
| 2024 | 1 | — | 0 | 32 |
| 2025 | 0 | — | 3 | 18 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
For short term application the indications for usc arc: nasal splinting; wound dressings; management of hypentrophic or kcloid scarring; to prevent soft rissu¢ fibrosis or bony ankylosis following surgical correction of trismus; temporary joint spacers; laboratory uses. For long-term application the indications for use are; nasal septal repair; orbital floor reconstruction; tympanic membrane rcpair: dialysis shunt anchoring: duramater repair; staged…
Read the full statement (126 words)
For short term application the indications for usc arc:
nasal splinting;
wound dressings;
management of hypentrophic or kcloid scarring;
to prevent soft rissu¢ fibrosis or bony ankylosis following surgical correction of trismus;
temporary joint spacers;
laboratory uses.
For long-term application the indications for use are;
nasal septal repair;
orbital floor reconstruction;
tympanic membrane rcpair:
dialysis shunt anchoring:
duramater repair;
staged repair of omphalaccic: -
for lengthening extra ocular muscles in select cascs of suabxsmus.
as a protective sheathing 10 help Facilitate neural regeneration and tendon anastomnosis;
as a protective sheathing to hclp facilitate osteogenesis;
guided tissue regeneration between teeth and gingival margin, ot external ear canal for example;
other uses deemed appropriate by the using surgeon.
Warning: Net for permanent use in Temporo Mandibular Joint applicasions,
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K983041 · printed Nov 4, 2026
Cite this page
510(k) Report. “K983041: Seare Biomedical Silicone Sheeting.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K983041
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026